Candel Therapeutics, Inc.

NASDAQ:CADL

4.83 (USD) • At close November 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 001.7760000.0310.0310.0310.0310.0310.0310.0310.0310.0310.0310.0310.031
Kosten van de omzet 0.2490.2510.3120.3060.2950.2870.2760.2580.2380.2150.1785.2653.2922.753001.7951.621
Brutowinst -0.249-0.2511.464-0.306-0.295-0.287-0.245-0.227-0.207-0.184-0.147-5.234-3.261-2.7220.0310.031-1.764-1.59
Brutowinstmarge 000.824000-7.903-7.323-6.677-5.935-4.742-168.839-105.194-87.80611-56.903-51.29
Onderzoek- en ontwikkelingskosten 4.733.8516.9465.8455.9345.4694.9725.3765.0225.4173.8545.2653.2922.7533.5341.8131.7951.621
Algemene en administratieve kosten 3.5923.83.063.0163.6454.1643.163.5363.7623.63.9172.7952.041.9352.6220.9670.8550.728
Verkoop- en marketingkosten 0.17800000000000000000
Verkoop-, algemene en administratieve kosten 3.5923.83.063.0163.6454.1643.163.5363.7623.63.9172.7952.041.9352.6220.9670.8550.728
Overige kosten -4.97900.01200-0.012-0.0485.3454.9915.38615.98-8.25-12.369-0.191-4.553-0.154-0.5070.455
Bedrijfskosten 8.3227.65110.0068.8619.5679.6218.0848.9128.7849.0177.6227.9294.7274.4976.0052.6262.4942.186
Bedrijfsresultaat -8.571-7.902-10.318-8.861-9.579-9.633-8.101-8.881-8.753-8.986-7.74-8.029-5.301-4.657-6.125-2.749-2.619-2.318
Bedrijfsresultaat ratio 00-5.81000-261.323-286.484-282.355-289.871-249.677-259-171-150.226-197.581-88.677-84.484-74.774
Totaal overige inkomsten en kosten netto -13.666-0.319-0.7770.5810.1440.8383.0180.1934.6048.1129.198-8.25-12.3690.179-4.5530.195-0.5070.455
Inkomen voor belasting -22.237-8.221-11.095-8.435-9.614-8.795-5.083-8.688-4.149-0.8741.596-16.162-17.08-4.478-10.478-2.554-2.876-1.772
Inkomen voor belasting ratio 00-6.247000-163.968-280.258-133.839-28.19451.484-521.355-550.968-144.452-338-82.387-92.774-57.161
Belastingkosten 00.2080.386-0.090.644-0.94-15.735-0.193-4.604-8.1120.0120.0140.0150.1914.5040.1540.4130.072
Nettowinst -22.237-8.221-11.095-8.435-9.614-7.85510.652-8.4950.4557.2381.596-16.162-17.08-4.478-10.478-2.554-2.876-1.772
Nettowinstmarge 00-6.247000343.613-274.03214.677233.48451.484-521.355-550.968-144.452-338-82.387-92.774-57.161
WPA (Winst Per Aandeel) -0.74-0.28-0.38-0.29-0.33-0.270.37-0.290.0160.250.068-0.69-0.69-0.24-0.56-0.14-0.15-0.095
Verwaterde WPA -0.74-0.28-0.38-0.29-0.33-0.270.37-0.290.0160.250.068-0.69-0.69-0.24-0.56-0.14-0.15-0.095
EBITDA -8.322-7.651-10.006-8.861-8.878-10.115-10.797-9.045-13.535-8.821-7.413-7.877-4.689-4.44-1.415-2.55-1.948-2.123
EBITDA ratio 00-5.634000-348.29-291.774-436.613-284.548-239.129-254.097-151.258-143.226-45.645-82.258-62.839-68.484